The North Kynouria Project
Mass Screening of the Population of the North Kynouria Municipality in Arcadia, Greece for the Detection of Cardiovascular and Stroke Risk Factors
1 other identifier
interventional
7,000
1 country
1
Brief Summary
The North Kynouria Project was initiated to study cardiovascular/stroke risk factors by employing mass screening and long-term surveillance of an adult population in the municipality of North Kynouria, in the county of Arcadia, Peloponnese, Greece. The North Kynouria Study was initiated to assess modifiable and non-modifiable determinants of cerebrovascular and coronary heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cardiovascular-diseases
Started Nov 2022
Typical duration for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedNovember 2, 2023
October 1, 2023
3.1 years
October 18, 2023
October 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Major adverse cardiovascular events
myocardial infarction, ischemic and hemorrhagic stroke
up to 5 years after enrollment
All-cause mortality
Death by any cause, cardiovascular, infection, cancer, other
up to 5 years after enrollment
Hospitalizations
Any cause hospitalization
up to 5 years after enrollment
Emergency room visits
Any cause of emergency room visit
up to 5 years after enrollment
Secondary Outcomes (5)
New diagnosis of Arterial hypertension
up to 1 year after enrollment
New diagnosis of diabetes mellitus
up to 1 year after enrollment
New diagnosis of dyslipidemia
up to 1 year after enrollment
New diagnosis of carotid atherosclerosis
up to 1 year after enrollment
New diagnosis of peripheral artery disease
up to 1 year after enrollment
Study Arms (1)
Patient screening
EXPERIMENTALSingle group, no masking, receiving the intervention
Interventions
Patient counseling, lifestyle modifications, medication evaluation, and adherence
Eligibility Criteria
You may qualify if:
- residents of North Kynouria
You may not qualify if:
- under 18,
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ioanninalead
- Hellenic Stroke Organizationcollaborator
- Municipality of North Kynouriacollaborator
- Greece 2021 Committeecollaborator
- Astros Health Care Centercollaborator
Study Sites (1)
Astros Health Care Center
Ástros, 220 01, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charalampos Milionis, MD, PhD
University of Ioannina
- PRINCIPAL INVESTIGATOR
George Ntaios, MD, MSc, PhD
University of Thessaly
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MSc, PhD
Study Record Dates
First Submitted
October 18, 2023
First Posted
November 2, 2023
Study Start
November 1, 2022
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
November 2, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 2024-2025
- Access Criteria
- Through access granting from the University of Ioannina
Study protocol details